Misuse of Drugs Act 1971

Section 2.

SCHEDULE 2 U.K. Controlled Drugs

Part I U.K. Class A Drugs

1 U.K. The following substances and products, namely:—

[F1 (a)]

• Acetorphine.

• [F2 Alfentanil.]

• Allylprodine.

• Alphacetylmethadol.

• Alphameprodine.

• Alphamethadol.

• Alphaprodine.

• Anileridine.

• Benzethidine.

• Benzylmorphine (3-benzylmorphine).

• Betacetylmethadol.

• Betameprodine.

• Betamethadol.

• Betaprodine.

• Bezitramide.

• Bufotenine.

• Cannabinol, except where contained in cannabis or cannabis resin.

• Cannabinol derivatives.

• [F3 Carfentanil.]

• Clonitazene.

• Coca leaf.

• Cocaine.

• Desomorphine.

• Dextromoramide.

• Diamorphine.

• Diampromide.

• Diethylthiambutene.

• [F4 Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).]

• DihydrocodeinoneO-carboxymethyloxime.

• [F5 Dihydroetorphine]

• Dimenoxadole.

• Dimepheptanol.

• Dimethylthiambutene.

• Dioxaphetyl butyrate.

• Diphenoxylate.

• Dipipanone.

• [F6 Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).]

• Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.

• Ethylmethylthiambutene.

• [F2 Eticyclidine.]

• Etonitazene.

• Etorphine.

• Etoxeridine.

• [F7 Etryptamine]

• Fentanyl.

• Furethidine.

• Hydrocodone.

• Hydromorphinol.

• Hydromorphone.

• Hydroxypethidine.

• Isomethadone.

• Ketobemidone.

• Levomethorphan.

• Levomoramide.

• Levophenacylmorphan.

• Levorphanol.

• [F3 Lofentanil]

• Lysergamide.

• Lysergide and otherN-alkyl derivatives of lysergamide.

• Mescaline.

• Metazocine.

• Methadone.

• Methadyl acetate.

• Methyldesorphine.

• Methyldihydromorphine (6-methyldihydromorphine).

• Metopon.

• Morpheridine.

• Morphine.

• Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.

• Myrophine.

• F8 . . .

• Nicomorphine (3,6-dinicotinoylmorphine).

• Noracymethadol.

• Norlevorphanol.

• Normethadone.

• Normorphine.

• Norpipanone.

• Opium, whether raw, prepared or medicinal.

• Oxycodone.

• Oxymorphone.

• Pethidine.

• Phenadoxone.

• Phenampromide.

• Phenazocine.

• [F9 Phencyclidine.]

• Phenomorphan.

• Phenoperidine.

• Piminodine.

• Piritramide.

• Poppy-straw and concentrate of poppy-straw.

• Proheptazine.

• Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).

• Psilocin.

• Racemethorphan.

• Racemoramide.

• Racemorphan.

• [F10 Remifentanil]

• [F2 Rolicyclidine.]

• [F11 Sufentanil.]

• [F2 Tenocylidine.]

• Thebacon.

• Thebaine.

• [F11 Tilidate.]

• Trimeperidine.

• [F12 4-Bromo-2,5-dimethoxy-a-methylphenethylamine].

• 4-Cyano-2-dimethylamino-4,4-diphenylbutane.

• 4-Cyano-1-methyl-4-phenyl-piperidine.

• N,N-Diethyltryptamine.

• N,N-Dimethyltryptamine.

• 2,5-Dimethoxy-a,4-dimethylphenethylamine.

• [F13 N-Hydroxy-tenamphetamine.]

• 1-Methyl-4-phenylpiperidine-4-carboxylic acid.

• 2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.

• [F14 4-Methyl-aminorex]

• 4-Phenylpiperidine-4-carboxylic acid ethyl ester.

[F15 (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

[F16 (ba) the following phenethylamine derivatives, namely:—

• Allyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

• 2-Amino-1-(3,4-dimethoxyphenyl)ethanol

• Benzyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 4-Bromo- b ,2,5-trimethoxyphenethylamine

• N -(4- sec -Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

• Cyclopropylmethyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)ethylamine

• 2-(4,7-Dimethoxy-2,3-dihydro-1 H -indan-5-yl)-1-methylethylamine

• 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

• 2-(1,4-Dimethoxy-2-naphthyl)ethylamine

• 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

• N -(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

• 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

• 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

• a , a -Dimethyl-3,4-methylenedioxyphenethylamine

• a , a -Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

• Dimethyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• N -(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

• 4-Iodo-2,5-dimethoxy- a -methylphenethyl(dimethyl)amine

• 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

• 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

• 2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine

• 2-Methoxyethyl( a -methyl-3,4-methylenedioxyphenethyl)amine

• 2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[ b ]furan-6-yl)-1-methylethylamine

• b -Methoxy-3,4-methylenedioxyphenethylamine

• 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

• 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

• 2-( a -Methyl-3,4-methylenedioxyphenethylamino)ethanol

• a -Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

• N -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine

• O -Methyl- N -( a -methyl-3,4-methylenedioxyphenethyl)hydroxylamine

• a -Methyl-4-(methylthio)phenethylamine

• b ,3,4,5-Tetramethoxyphenethylamine

• b ,2,5-Trimethoxy-4-methylphenethylamine; ]

(c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N -alkylphenethylamine,a-methylphenethylamine, an N -alkyl-a-methylphenethylamine,a-ethylphenethylamine, or an N -alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents. ]

[F17 (d) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi) by replacement of the N-propionyl group by another acyl group;

(e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii) by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v) by formation of an N-oxide or of a quaternary base.]

Textual Amendments

F1 "(a)" inserted by S.I. 1977/1243, art. 3(a)

F2 Word inserted by S.I. 1984/859, art. 2(2)

F3 Word inserted by S.I. 1986/2230, art. 2(2)(a)

F4 Word inserted by S.I. 1975/421, art. 3

F5 Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), art. 2(2)(a)

F6 Word inserted by S.I. 1973/771, art. 2

F7 Word in Sch. 2 Pt. I para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(2)

F8 Words repealed by S.I. 1973/771, art. 2

F9 Word inserted by S.I. 1979/299, art. 2

F10 Word in Sch. 2 Pt. 1 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), art. 2(2)(b)

F11 Word inserted by S.I. 1983/765, art. 2(a)

F12 Words inserted by S.I. 1975/421, art. 3

F13 Word inserted by S.I. 1990/2589, art. 2(a)(i)

F14 Word inserted by S.I. 1990/2589, art. 2(a)(ii)

F15 Sch. 2 Pt. I para. 1(b)(c) added by S.I. 1977/1243, art. 3(b)

F16 Sch. 2 Pt. I para. 1(ba) inserted (1.2.2002) by The Misuse of Drugs Act 1971 (Modification) Order 2001 (S.I. 2001/3932), art. 2(2)

F17 Sch. 2 Pt. I para. 1(d)(e) added by S.I. 1986/2230, art. 2(2)(b)

2 U.K. Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.

3 U.K. Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [F18 not being a substance for the time being specified in Part II of this Schedule].

Textual Amendments

F18 Words inserted by S.I. 1973/771, art. 2

4 U.K. Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.

5 U.K. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.

6 U.K. Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.

Part II U.K. Class B Drugs

1 U.K. The following substances and products, namely:—

[F19 F20 (a)]

• Acetyldihydrocodeine.

• Amphetamine.

• Cannabis and cannabis resin.

• Codeine.

• F21 . . .

• Dihydrocodeine.

• Ethylmorphine (3-ethylmorphine).

• [F22 Glutethimide.]

• [F22 Lefetamine.]

• [F23 Mecloqualone.]

• [F23 Methaqualone.]

• [F24 Methcathinone]

• Methylamphetamine.

• [F25 a-Methylphenethylhydroxylamine]

• Methylphenidate.

• [F23 Methylphenobarbitone.]

• Nicocodine.

• [F26 Nicodicodine (6-nicotinoyldihydrocodeine).]

• Norcodeine.

• [F27 Pentazocine.]

• Phenmetrazine.

• Pholcodine.

• [F28 Propiram.]

• [F24 Zipeprol]

[F19 (b) any 5,5 disubstituted barbituric acid.]

Textual Amendments

F19 Sch. 2 Pt. 2 para. 1(b) added by S.I. 1984/859, art. 2(3)

F20 "(a)" inserted by S.I. 1984/859, art. 2

F21 Word repealed by S.I. 1985/1995, art. 2(2)(a)

F22 Word inserted by S.I. 1985/1995, art. 2(2)(b)

F23 Word inserted by S.I. 1984/859, art. 2(3)

F24 Words in Sch. 2 Pt. 2 para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(3)

F25 Word in Sch. 2 Pt. 2 para. 1(a) inserted (1.2.2002) by S.I. 2001/3932, art. 2(3)

F26 Words inserted by S.I. 1973/771, art. 2

F27 Word inserted by S.I. 1985/1995, art. 2(2)(c)

F28 Word inserted by S.I. 1973/771, art. 2

2 U.K. Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.

3 U.K. Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4 U.K. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.

Part III U.K. Class C Drugs

1 U.K. The following substances, namely:—

• [F30 Alprazolam.]

• [F31 Aminorex]

• Benzphetamine.

• [F30 Bromazepam.]

• [F31 Brotizolam]

• [F32 Buprenorphine]

• [F30 Camazepam.]

• [F33 Cathine.]

• [F33 Cathinone.]

• [F30 Chlordiazepoxide.]

• Chlorphentermine.

• [F30 Clobazam.]

• [F30 Clorazepic acid.]

• [F30 Clonazepam.]

• [F30 Clotiazepam.]

• [F30 Cloxazolam.]

• [F30 Delorazepam.]

• [F34 Dextropropoxyphene.]

• [F30 Diazepam.]

• [F35 Diethylpropion.]

• [F30 Estazolam.]

• [F30 Ethchlorvynol.]

• [F30 Ethinamate.]

• [F30 Ethyl loflazepate.]

• [F33 Fencamfamin.]

• [F33 Fenethylline.]

• [F33 Fenproporex.]

• [F30 Fludiazepam.]

• [F30 Flunitrazepam.]

• [F30 Flurazepam.]

• [F30 Halazepam.]

• [F30 Haloxazolam.]

• [F36 4-Hydroxy-n-butyric acid]

• [F30 Ketazolam.]

• [F30 Loprazolam.]

• [F30 Lorazepam.]

• [F30 Lormetazepam.]

• [F30 Mazindol.]

• [F30 Medazepam.]

• [F33 Mefenorex.]

• F37 . . .

• Mephentermine.

• [F30 Meprobamate.]

• [F31 Mesocarb]

• F38 . . .

• [F30 Methyprylone.]

• [F39 Midazolam.]

• [F30 Nimetazepam.]

• [F30 Nitrazepam.]

• [F30 Nordazepam.]

• [F30 Oxazepam.]

• [F30 Oxazolam.]

• [F40 Pemoline.]

• F37 . . .

• Phendimetrazine.

• [F30 Phentermine.]

• [F30 Pinazepam.]

• F37 . . .

• Pipradrol.

• [F30 Prazepam.]

• F37 . . .

• F41 . . .

• [F33 Pyrovalerone.]

• [F30 Temazepam.]

• [F30 Tetrazepam.]

• [F30 Triazolam.]

• [F33 N-Ethylamphetamine.]

• [F42 Zolpidem]

• [F43 (b) [F44 4-Androstene-3, 17-dione]

• [F44 5-Androstene-3, 17-diol]

• Atamestane.

• Bolandiol.

• Bolasterone.

• Bolazine.

• Boldenone.

• Bolenol.

• Bolmantalate.

• Calusterone.

• 4-Chloromethandienone.

• Clostebol.

• Drostanolone.

• Enestebol.

• Epitiostanol.

• Ethyloestrenol.

• Fluoxymesterone.

• Formebolone.

• Furazabol.

• Mebolazine.

• Mepitiostane.

• Mesabolone.

• Mestanolone.

• Mesterolone.

• Methandienone.

• Methandriol.

• Methenolone.

• Methyltestosterone.

• Metribolone.

• Mibolerone.

• Nandrolone.

• [F45 19-Nor-4-Androstene-3, 17-dione]

• [F45 19-Nor-5-Androstene-3, 17-diol]

• Norboletone.

• Norclostebol.

• Norethandrolone.

• Ovandrotone.

• Oxabolone.

• Oxandrolone.

• Oxymesterone.

• Oxymetholone.

• Prasterone.

• Propetandrol.

• Quinbolone.

• Roxibolone.

• Silandrone.

• Stanolone.

• Stanozolol.

• Stenbolone.

• Testosterone.

• Thiomesterone.

• Trenbolone.

(c) any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i) by further substitution at position 17 by a methyl or ethyl group;

(ii) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv) by fusion of ring A with a heterocyclic system;

(d) any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

• (e) Chorionic Gonadotrophin (HCG).

• Clenbuterol.

• Non-human chorionic gonadotrophin.

• Somatotropin.

• Somatrem.

• Somatropin.]

Textual Amendments

F29 "(a)" inserted (1.9.1996) by S.I. 1996/1300, art. 2(2)(a)

F30 Word inserted by S.I. 1985/1995, art. 2(3)

F31 Words in Sch. 2 Pt. 3 para. 1(a) inserted (1.5.1998) by S.I. 1998/750, art. 2(4)

F32 Word inserted by S.I. 1989/1340, art. 2(a)

F33 Word inserted by S.I. 1986/2230, art. 2(3)

F34 Word inserted by S.I. 1983/765, art. 2(a)

F35 Word inserted by S.I. 1984/859, art. 2(4)(a)

F36 Word in Sch. 2 Pt. 3 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(3)(a)

F37 Words repealed by S.I. 1973/771, art. 2

F38 Word repealed by S.I. 1984/859, art. 2(4)(a)

F39 Word inserted by S.I. 1990/2589, art. 2(b)

F40 Word inserted by S.I. 1989/1340, art. 2(b)

F41 Word in Sch. 2 Pt. 3 para.1 omitted (1.9.1995) by virtue of S.I. 1995/1966, art. 2

F42 Word in Sch. 2 Pt. 3 para. 1(a) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(3)(b)

F43 Sch. 2 Pt. 3 para. 1(b)-(e) added (1.9.1996) by S.I. 1996/1300, art. 2(2)(b)

F44 Word in Sch. 2 Pt. 3 para. 1(b) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(4)(a)

F45 Word in Sch. 2 Pt. 3 para. 1(b) inserted (1.7.2003) by The Misuse of Drugs Act 1971 (Modification) Order 2003 (S.I. 2003/1243), arts. 1, 2(4)(b)

2 U.K. Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule [F46 not being phenylpropanolamine.]

Textual Amendments

F46 Words added by S.I. 1986/2230, art. 2(4)

3 U.K. Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.

4 U.K. Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.

Part IV U.K. Meaning of certain Expressions used in this Schedule

For the purposes of this Schedule the following expressions (which are not among those defined in section 37(1) of this Act) have the meanings hereby assigned to them respectively, that is to say—

• “cannabinol derivatives” means the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives;

• “coca leaf” means the leaf of any plant of the genusErythroxylonfrom whose leaves cocaine can be extracted either directly or by chemical transformation;

• “concentrate of poppy-straw” means the material produced when poppy-straw has entered into a process for the concentration of its alkaloids;

• “medicinal opium” means raw opium which has undergone the process necessary to adapt it for medicinal use in accordance with the requirements of the British Pharmacopoeia, whether it is in the form of powder or is granulated or is in any other form, and whether it is or is not mixed with neutral substances;

• “opium poppy” means the plant of the speciesPapaver somniferum L;

• “poppy straw” means all parts, except the seeds, of the opium poppy, after mowing;

• “raw opium” includes powdered or granulated opium but does not include medicinal opium.